MIRAE ASSET SECURITIES (USA) INC.’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
MIRAE ASSET SECURITIES (USA) INC.'s BIIB Position: Q3 2025 in Review
MIRAE ASSET SECURITIES (USA) INC. sold out of Biogen (BIIB) in Q3 2025, closing a stake of 23,059 shares — an estimated $2.9M sold.
MIRAE ASSET SECURITIES (USA) INC. first reported a position in BIIB in Q4 2024 and held it in 3 quarters. The position peaked at $6.13M in Q4 2024. 906 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.
- MIRAE ASSET SECURITIES (USA) INC. reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
- MIRAE ASSET SECURITIES (USA) INC. sold 23,059 Biogen shares in Q3 2025, an estimated $2.9M.
- MIRAE ASSET SECURITIES (USA) INC. first reported a position in Biogen in Q4 2024 and held it in 3 quarters.
- MIRAE ASSET SECURITIES (USA) INC.'s Biogen position peaked at $6.13M in Q4 2024.
- 906 funds tracked by Wall St. Rank held Biogen as of Q3 2025.
Based on MIRAE ASSET SECURITIES (USA) INC.'s 13F filing for Q3 2025, filed 24 Oct 2025.